Authors:
HARTLEYASP B
VUKANOVIC J
JOSEPH IBJK
STRANDGARDEN K
POLACEK J
ISAACS JT
Citation: B. Hartleyasp et al., ANTI-ANGIOGENIC TREATMENT WITH LINOMIDE AS ADJUVANT TO SURGICAL CASTRATION IN EXPERIMENTAL PROSTATE-CANCER, The Journal of urology, 158(3), 1997, pp. 902-907
Citation: Ibjk. Joseph et al., ANTIANGIOGENIC TREATMENT WITH LINOMIDE AS CHEMOPREVENTION FOR PROSTATE, SEMINAL-VESICLE, AND BREAST CARCINOGENESIS IN RODENTS, Cancer research, 56(15), 1996, pp. 3404-3408
Authors:
BERGES RR
VUKANOVIC J
EPSTEIN JI
CARMICHEL M
CISEK L
JOHNSON DE
VELTRI RW
WALSH PC
ISAACS JT
Citation: Rr. Berges et al., IMPLICATION OF CELL KINETIC CHANGES DURING THE PROGRESSION OF HUMAN PROSTATIC-CANCER, Clinical cancer research, 1(5), 1995, pp. 473-480
Citation: J. Vukanovic et al., INHIBITION OF TUMOR ANGIOGENESIS AND THE THERAPEUTIC ABILITY OF LINOMIDE AGAINST RAT PROSTATIC CANCERS, The Prostate, 26(5), 1995, pp. 235-246
Citation: J. Vukanovic et Jt. Isaacs, LINOMIDE INHIBITS ANGIOGENESIS, GROWTH, METASTASIS, AND MACROPHAGE INFILTRATION WITHIN RAT PROSTATIC CANCERS, Cancer research, 55(7), 1995, pp. 1499-1504
Citation: J. Vukanovic et Jt. Isaacs, HUMAN PROSTATIC-CANCER CELLS ARE SENSITIVE TO PROGRAMMED (APOPTOTIC) DEATH INDUCED BY THE ANTIANGIOGENIC AGENT LINOMIDE, Cancer research, 55(16), 1995, pp. 3517-3520
Citation: J. Vukanovic et Jt. Isaacs, MECHANISM OF LINOMIDES ANTIANGIOGENIC AND CHEMOPREVENTIVE ABILITIES, Journal of cellular biochemistry, 1994, pp. 245-245